Glenmark Pharmaceuticals
Andheri
About Glenmark Pharmaceuticals
Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 10,001+
- Estimated revenue: $1M – $10M
- Total funding: $58.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: bom:532296
- Website: glenmarkpharma.com
- Phone: +91 22 4018 9999
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/glenmark-pharmaceuticals-105398 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.